Skip to main content
Clinical Trials/DRKS00015860
DRKS00015860
Recruiting
N/A

Intensive Care Treatment of Cardiogenic Shock and Post-cardiac Arrest Patients Registry - LMUshock

Klinikum der Universität München, Campus Großhadern0 sites1,000 target enrollmentNovember 21, 2019

Overview

Phase
N/A
Intervention
Not specified
Conditions
R57.0
Sponsor
Klinikum der Universität München, Campus Großhadern
Enrollment
1000
Status
Recruiting
Last Updated
last year

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
November 21, 2019
End Date
TBD
Last Updated
last year
Study Type
Observational
Sex
All

Investigators

Sponsor
Klinikum der Universität München, Campus Großhadern

Eligibility Criteria

Inclusion Criteria

  • Patients with cardiogenic shock or after cardiopulmonary resuscitation of any cause with a minimum age of 18 years, who have been treated on the intensive care unit since the year 2012\. Cardiogenic shock was defined by ESC guidelines, the IABP\-SHOCK II trial and CULPRIT Shock trial as follows: hypotension despite adequate filling status (systolic blood pressure \< 90 mmHg for 30 minutes or catecholamines to maintain systolic blood pressure \> 90 mmHg) and signs of pulmonary congestion and at least one of the following clinical and laboratory signs of hypoperfusion: altered mental status, dizziness, cold, clammy skin and extremities, oliguria with urine output \< 30ml/h, narrow pulse pressure, metabolic acidosis, elevated serum lactate \> 2mmol/l, elevated creatinine, due to primary cardiac dysfunction.

Exclusion Criteria

  • Not provided

Outcomes

Primary Outcomes

Not specified

Similar Trials